R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
Back to search
Official data from USPTO
SPL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
04/10/2024
Trademark type
Word
Nice classes
5, 40, 42
Filing date
04/20/2023
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/1976
First use in commerce
01/01/1976
Drawing code
4
Owner type
03
Owner location
Langhorne, PA
Examiner
BONEN-CLARK, HOPE MICHELLE
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hepalink USA Inc.
Representatives
Gordon M. Wright REINHART BOERNER AND VAN DEUREN P.C.
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products and preparations containing active pharmaceutical ingredientspharmaceutical grade Heparin Sodiumpharmaceutical grade Pancreatinpharmaceutical grade Pancrealipasefor use in humans for the prevention and treatment of thrombotic events and to treat pancreatic insufficiency and related diseases; Pharmaceutical products and preparationsanticoagulants; pharmaceutical products and preparations for the testingsampling and identification of virusesmedical diagnostic reagents and assays for testing of body fluids; Chemical preparations for sanitary use; Chemical preparations for treating mildew; Diagnostic preparations for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating thyroid conditions; Pharmaceutical preparations for wounds; Diagnostic preparations for use with medical devices; Pharmaceutical preparations for treating thrombotic events and pancreatic insufficiency for use with medical devices for drug delivery; Pharmaceutical preparations for ophthalmological usefor treating eye diseases and disorders; none of the foregoing for use with animals
Class 40
Manufacturing services for others in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compoundsthe extractionisolation and purification of naturally derived and fermentation-derived therapeutic compounds
Class 42
Pharmaceutical contract development in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compoundsthe extractionisolation and purification of naturally derived and fermentation-derived therapeutic compounds
Publications
History of USPTO decisions and trademark events.
19 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/07/2023
GNRT
NON-FINAL ACTION E-MAILED
08/07/2023
CNRT
NON-FINAL ACTION WRITTEN
08/07/2023
DOCK
ASSIGNED TO EXAMINER
07/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/17/2023
NWAP
NEW APPLICATION ENTERED
04/24/2023
Continuous trademark protection
Get notified about every new filing that threatens SPL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.